Exchange Announcement • 30 Sep 2026 17:27
Change Of Company Name Of Singapore Share Transfer Agent
Exchange Announcement • 14 Sep 2026 18:21
Voluntary And Business Update Announcement Approval Of Drug Clinical Trials For Systemic Lupus Erythematosus Of Innovative Drug Highly Selective Tyk2 Inhibitor Cms-D001
Exchange Announcement • 03 Sep 2026 17:54
Voluntary And Business Update Announcement New Drug Application For Additional Indication Atopic Dermatitis (Ad) For Ruxolitinib Phosphate Cream Lumirix Approved In China
Exchange Announcement • 01 Sep 2026 17:21
Letter To Non-Registered Shareholders - Reminder Letter Regarding The Arrangement Of Electronic Dissemination Of Corporate Communications And Reply Form
Exchange Announcement • 01 Sep 2026 17:17
